Utility of Induced Pluripotent Stem Cell-Based Microphysiological Systems for Drug Development and Testing
2025 (English)In: Cell-Based Assays Using iPSCs for Drug Development and Testing / [ed] Carl-Fredrik Mandenius, James A. Ross, Humana Press Inc. , 2025, Vol. 2924, p. 165-187Chapter in book (Refereed)
Abstract [en]
Microphysiological systems (MPS), i.e., miniaturized mimics of active biological systems, are considered resourceful tools for facilitating drug development. It presupposes that a microphysiological system can respond as organs and tissues in the human body to new drug candidates and that relevant cellular response can be monitored. If, or when, this is possible, microphysiological systems have the potential to support and accelerate the development and testing of new drug candidates. So far, the focus has been more on the design and fabrication of the microarchitecture of the MPS to recreate their cellular counterparts as closely and realistically as possible. Commercial MPS devices have been developed that focus on advanced technological design solutions, sometimes more than their actual biological functionality. This chapter discusses in brief terms the prerequisites for the design and construction of MPS devices in relation to their utility for drug development and testing in a more holistic manner. The use of induced pluripotent cells as a prime source for mimicking the in vivo conditions of diseased conditions is mainly considered. Existing limitations and needs are highlighted in relation to the space for improvements, based on recently published results.
Place, publisher, year, edition, pages
Humana Press Inc. , 2025. Vol. 2924, p. 165-187
Keywords [en]
Conceptual design, Drug assessment, In vivo-like, Microfluidics, Microplates, Microsensors, Organ-on-a-chip, Organoids, Stem cells, Animals, Cell Culture Techniques, Drug Development, Drug Evaluation, Preclinical, Humans, Induced Pluripotent Stem Cells, Microphysiological Systems, polymer, analytic method, biosynthesis, cell culture, chemical modification, drug design, drug screening, equipment design, feedback system, human, induced pluripotent stem cell, metabolomics, microtechnology, organoid, pharmaceutical care, reproducibility, soft lithography, surface property, three dimensional printing, tissue culture, animal, cell culture technique, cytology, devices, drug effect, metabolism, organ on a chip, preclinical study, procedures
National Category
Design
Identifiers
URN: urn:nbn:se:liu:diva-225989DOI: 10.1007/978-1-0716-4530-7_12PubMedID: 40307642Scopus ID: 2-s2.0-105004481314Libris ID: 3q0xghn21wf7lr5qISBN: 9781071645291 (print)ISBN: 9781071645307 (electronic)OAI: oai:DiVA.org:liu-225989DiVA, id: diva2:2082829
2026-07-012026-07-012026-10-29Bibliographically approved